3h
Investor's Business Daily on MSNWhy IBD 50's Top Seed, Hims & Hers, Just Crashed On Its Upbeat EarningsHims stock plunged Tuesday after the compounding pharmacy issued a bullish outlook that still includes knockoff versions of ...
3h
Investor's Business Daily on MSNIBD Stock Of The Day: Coupang Looks To Build Off 2024 Gains With Earnings DueFounded in 2010 with its corporate headquarters in Seattle, Coupang operates the leading e-commerce marketplace in South ...
A British study found that virtual chromoendoscopy has a higher neoplasia detection rate than other endoscopic modalities ...
A ginger compound, furanodienone (FDN), has been found to reduce inflammation and repair gut damage in IBD patients by ...
Trillions of microbes live inside us. Many are helpful; others, not so much. Over the last 15 years MIT has played a central ...
By adjusting the fat levels in mRNA-based drugs, researchers have found a way to bypass the liver and go straight to the ...
Sanofi & Teva's IBD drug duvakitug shows promise in Phase 2b with €1B sales potential by 2032, faces competition from Roivant ...
Factors linked to C difficile infection in patients with IBD include IBD activity prior to infection, shorter disease ...
Researchers have identified a compound in ginger that could treat some symotoms of inflammatory bowel disease. | Cell And ...
Under this transaction, Organovo will receive an upfront payment as well as milestones to be paid as FXR314 achieves key regulatory and commercial milestones. Lilly is acquiring all commercial and ...
Up to 40% of patients with inflammatory bowel disease (IBD) experience extraintestinal manifestations (EIMs), with the ...
VAXXITEK® HVT+IBD+H5 is a new trivalent vaccine for poultry that offers protection against Marek’s disease, Infectious Bursal Disease and H5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results